Search results
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Morningstar· 1 week agoMore than 20 million people in the U.S. are living with peripheral artery disease (PAD) yet there have been limited treatment optionsThe first-of-its-kind Espritâ„¢ BTK Everolimus Eluting Resorbable ...